Feedback / Questions
Siliq (brodalumab) - Bausch Health, LEO Pharma, Kyowa Hakko Kirin
Brodalumab: Regulatory decision in China for psoriasis in H2 2020
(Kyowa Hakko Kirin Pharma)
-
May 1, 2020 -
Q1 2020 Results
Non-US regulatory
•
Immunology • Psoriasis
https://ir.kyowakirin.com/en/library/earnings/earnings0/main/03/teaserItems1/00/linkList/01/link/presentation_2020_q1_en2.pdf
May 1, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious